MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Intermediaries
Intermediaries: Conferences, Meetings and Networking Venues
Conferences and Meetings
Defense TechConnect
*2019: TechConnect: DITAC Participating Companies (2019)
AntiRadical Therapeutics, LLC
Organization & Developments: AntiRadical Therapeutics
Parents
AntiRadical Therapeutics, LLC
Children
AntiRadical Therapeutics' pipeline of nitroxide-based therapeutics have been shown effective in diverse neurological conditions.
SanFlow is a prehospital treatment for the extension of the Golden Hour to 72 hours in severe traumatic brain injury accompanied by hemorrhagic shock.
SanFlow is being developed to: (1) correct vascular dysfunction and inflammatory reactions (2) prevent organ injuries and death in brain injuries, hemorrhagic shock, cancer, stroke, Alzheimer's Disease, COVID-19 infections and other conditions.
SanFlow’s use in Prolonged Field Care, the top priority capability gap across the US Army, is highlighted.
Supported by DoD's JPC-6 Combat Casualty Care Research Program
Jumps
*Key People: AntiRadical Therapetics
Finance & Acquisitions: AntiRadical Therapeutics